Results 31 to 40 of about 2,249,117 (300)

Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion [PDF]

International Journal of Ophthalmology, 2022
AIM: To investigate the anti-inflammatory effect of intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) in patients with macular edema secondary to retinal vein occlusion (RVO-ME).
Hai-Feng Qin, Fan-Jun Shi, Chao-Yang Zhang, Da-Wei Luo, Shi-Yue Qin, Jing Wu, Hai Xie, Jing-Ting Zhang, Qing-Hua Qiu, Kun Liu, Guo-Tong Xu, Guo-Xu Xu, Jing-Fa Zhang   +12 more
doaj   +1 more source

Trends, geographical variation and factors associated with the use of anti-VEGF intravitreal injections in Portugal (2013–2018): a retrospective analysis of administrative data

BMJ Open, 2022
Aims The arrival of anti-vascular endothelial growth factor (anti-VEGF) therapies represented a treatment shift for several ophthalmological disorders and led to an increasing number of patients undergoing intravitreal injections.
Ana Patricia Marques, Rui Santana, António Filipe Macedo, Pedro Laires, João Victor Rocha, Marta Afonso-Silva, Ana Sofia Almeida, Julieta Fernandes, Marisa Pardal   +8 more
doaj   +1 more source

Anti-VEGF Treatments and Marketing. [PDF]

Rom J Ophthalmol
Gheorghe CM.
europepmc   +3 more sources

La resistencia adaptativa a terapias antiangiogénicas en un modelo murino de cáncer [PDF]

, 2011
Los objetivos de este estudio son: 1. Caracterización de la resistencia a la inhibición farmacológica de la angiogénesis: a. Caracterización de la resistencia a la inhibición selectiva de la vía VEGF/VEGFR2. b.
Pàez Ribes, Marta
core   +7 more sources

Anti-vascular endothelial growth factor monotherapy or combined with verteporfin photodynamic therapy for retinal angiomatous proliferation: a systematic review with meta-analysis

Frontiers in Pharmacology, 2023
Purpose: To assess functional and anatomical outcomes of intravitreal anti-Vascular Endothelial Growth Factor (anti-VEGF) monotherapy versus combined with verteporfin Photodynamic Therapy (PDT) for Retinal Angiomatous Proliferation (RAP).Methods: Studies
Matteo Fallico, Iacopo Macchi, Andrea Maugeri, Giuliana Favara, Martina Barchitta, Roberta Magnano San Lio, Antonella Agodi, Andrea Russo, Antonio Longo, Teresio Avitabile, Niccolò Castellino, Michele Reibaldi, Francesco Pignatelli, Maria Vadalà, Clara Patanè, Marcella Nebbioso, Vincenza Bonfiglio   +16 more
doaj   +1 more source

Modulated anti-VEGF therapy under the influence of lipid metabolizing proteins in Age related macular degeneration: a pilot study

Scientific Reports, 2022
Age-related macular degeneration (AMD) is a devastating retinal disease that results in irreversible vision loss in the aged population. The complex genetic nature and degree of genetic penetrance require a redefinition of the current therapeutic ...
Kaushal Sharma, Priya Battu, Ramandeep Singh, Suresh Kumar Sharma, Akshay Anand   +4 more
doaj   +1 more source

VEGF(164)-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization [PDF]

, 2003
Hypoxia-induced VEGF governs both physiological retinal vascular development and pathological retinal neovascularization. In the current paper, the mechanisms of physiological and pathological neovascularization are compared and contrasted.
Ogura, Y, Ng, Yin-Shan, Adamis, Anthony P., Kenji Yamashiro, Usui, Tomohiko, Hida, Tetsuo, Yuichi Kaji, Evangelos S. Gragoudas, Yin-Shan Ng, Shiro Amano, Amano, Shiro, Miller, Joan W., Yuichiro Ogura, Patricia A. D'Amore, Ambati, Jayakrishna, Shima, David T., Gragoudas, Evangelos S., Miller, JW, D'Amore, PA, Yoshihisa Oguchi, Hida, T, Ishida, S, Gragoudas, ES, Usui, T, Tetsuo Hida, Ogura, Yuichiro, Tomohiko Usui, Jayakrishna Ambati, Shima, DT, Joan W. Miller, Kaji, Yuichi, D\u27Amore, Patricia A., Ambati, J, Adamis, AP, Anthony P. Adamis, Kaji, Y, Yamashiro, K, Amano, S, Oguchi, Y, Oguchi, Yoshihisa, David T. Shima, Yamashiro, Kenji, Susumu Ishida, Ishida, Susumu, Ng, YS   +44 more
core   +1 more source

Intravitreal anti-vascular endothelial growth factor, laser photocoagulation, or combined therapy for diabetic macular edema: A systematic review and network meta-analysis

Frontiers in Endocrinology, 2023
PurposeTo conduct a network meta-analysis (NMA) comparing the efficacy of anti-vascular endothelial growth factor (VEGF) therapy alone versus laser photocoagulation (LP) therapy alone or anti-VEGF therapy combined with LP therapy for diabetic macular ...
Jiasheng Chen, Jiasheng Chen, Haowei Wang, Haowei Wang, Weiqiang Qiu, Weiqiang Qiu   +5 more
doaj   +1 more source

Anti-VEGF– and anti-VEGF receptor–induced vascular alteration in mouse healthy tissues [PDF]

Proceedings of the National Academy of Sciences, 2013
Systemic therapy with anti-VEGF drugs such as bevacizumab is widely used for treatment of human patients with various solid tumors. However, systemic impacts of such drugs in host healthy vasculatures remain poorly understood. Here, we show that, in mice, systemic delivery of an anti-VEGF or an anti–VEGF receptor (VEGFR)-2 neutralizing antibody caused ...
Y. Yang, Y. Zhang, Z. Cao, H. Ji, X. Yang, H. Iwamoto, E. Wahlberg, T. Lanne, B. Sun, Y. Cao   +9 more
openaire   +2 more sources

VEGF family members : modulators of tumor angiogenesis and lymphangiogenesis [PDF]

, 2006
Members of the vascular endothelial growth factor (VEGF) family and their receptors (VEGFR) play an essential role in the development and maintenance of the blood and lymphatic vasculature.
Kopfstein, Lucie
core   +1 more source